FDA Actions

Do Erythropoiesis-Stimulating Agents Have a Risk Evaluation and Mitigation Strategy?

Epoetin alfa and darbepoetin alfa are erythropoiesis-stimulating agents (ESAs), approved for the treatment of anemia (low red blood cells [RBCs])...